Showing results (161-170 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|August 19, 2003
A simple formula for sample size calculation in equivalence studiesPaul ZhangJournal of Biopharmaceutical Statistics|March 19, 2004
Assessing tumor-related signs and symptoms to support cancer drug approvalGrant Williams, Richard Pazdur, Robert TempleJournal of Biopharmaceutical Statistics|October 31, 2003
A decision rule for evaluating several independent clinical trials collectivelyQian H Li, Mohammad F HuqueJournal of Biopharmaceutical Statistics|October 31, 2003
Protocol designed subgroup analyses in multiarmed clinical trials: multiplicity aspectsEgbert H E Biesheuvel, Ludwig A HothornJournal of Biopharmaceutical Statistics|October 31, 2003
Using graphical displays of exact overall significance levels as a guideline for choosing a significance level for pairwise comparisons of a dichotomous variableFredrick S WhaleyJournal of Biopharmaceutical Statistics|June 23, 2004
Multiple testing of noninferiority hypotheses in active controlled trialsH M James Hung, Sue-Jane WangJournal of Biopharmaceutical Statistics|June 23, 2004
Two simulation methods for constructing confidence bands under the additive risk modelGuosheng Yin, Jianhua HuJournal of Biopharmaceutical Statistics|July 1, 1994
Practical modifications of the continual reassessment method for phase I cancer clinical trialsD FariesJournal of Biopharmaceutical Statistics|July 1, 1994
Implications of chance baseline differences in repeated measurement designsJ E Overall, S R DoyleJournal of Biopharmaceutical Statistics|September 11, 2019
Performance evaluation of regression splines for propensity score adjustment in post-market safety analysis with multiple treatmentsYuxi Tian, Elande Baro, Rongmei ZhangPageof 216